Brown Advisory Inc. trimmed its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 98.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,413 shares of the technology company's stock after selling 924,505 shares during the quarter. Brown Advisory Inc.'s holdings in Amdocs were worth $1,319,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Alyeska Investment Group L.P. raised its position in Amdocs by 86.8% during the fourth quarter. Alyeska Investment Group L.P. now owns 1,681,074 shares of the technology company's stock valued at $143,127,000 after acquiring an additional 781,061 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Amdocs by 25.4% during the fourth quarter. Wellington Management Group LLP now owns 2,680,422 shares of the technology company's stock worth $228,211,000 after purchasing an additional 543,490 shares in the last quarter. Vanguard Group Inc. boosted its stake in Amdocs by 16.1% during the fourth quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock worth $261,756,000 after buying an additional 426,035 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in Amdocs by 2,489.0% during the fourth quarter. The Manufacturers Life Insurance Company now owns 376,383 shares of the technology company's stock worth $32,045,000 after buying an additional 361,845 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its stake in shares of Amdocs by 32.8% in the 4th quarter. Russell Investments Group Ltd. now owns 979,861 shares of the technology company's stock valued at $83,426,000 after purchasing an additional 242,093 shares during the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on DOX. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a report on Saturday, June 7th. Wolfe Research began coverage on Amdocs in a research report on Tuesday, July 8th. They issued an "outperform" rating for the company. Five analysts have rated the stock with a buy rating, According to MarketBeat, Amdocs presently has an average rating of "Buy" and an average price target of $105.33.
Read Our Latest Stock Analysis on DOX
Amdocs Price Performance
Shares of DOX traded up $0.14 during mid-day trading on Thursday, hitting $89.31. The company's stock had a trading volume of 453,256 shares, compared to its average volume of 664,323. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.21. The firm has a 50-day simple moving average of $91.56 and a 200 day simple moving average of $88.37. The firm has a market capitalization of $10.08 billion, a P/E ratio of 18.80, a P/E/G ratio of 1.47 and a beta of 0.52. Amdocs Limited has a 1-year low of $78.61 and a 1-year high of $95.41.
Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.07. The firm had revenue of $1.13 billion during the quarter, compared to analysts' expectations of $1.12 billion. Amdocs had a return on equity of 19.52% and a net margin of 11.39%. Amdocs's revenue was down 9.4% on a year-over-year basis. During the same period in the previous year, the firm posted $1.56 earnings per share. Analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Monday, June 30th will be given a $0.527 dividend. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date of this dividend is Monday, June 30th. Amdocs's dividend payout ratio is currently 44.42%.
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
